Diltiazem reduces pulmonary arterial pressures in recurrent pulmonary hypertension associated with pulmonary hypoplasia

Journal of Pediatric Surgery

Volumn 34, Issue 5, 1999, Pages 712-714

  Islam, Saleem ^a   Masiakos, Peter ^a   Schnitzer, Jay J ^a   Doody, Daniel P ^a   Ryan, Daniel P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Calcium channel antagonist; Extracorporeal membrane oxygenation; Recurrent pulmonary hypertension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NITRATE; NITRIC OXIDE; PROSTAGLANDIN;

CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG HYPOPLASIA; MALE; MULTIPLE ORGAN FAILURE; NEWBORN; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SEPSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0032901463     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(99)90361-5     Document Type: Conference Paper

References (10)

1. Dillon PW, Cilley RE, Hudome SM, et al: Nitric oxide reversal of recurrent pulmonary hypertension and respiratory failure in an infant with CDH after successful ECMO therapy. J Pediatr Surg 30:743-744, 1995
2. Rich S, Brundage BH: High-dose calcium channel blocking therapy for primary pulmonary hypertension: Evidence for long term reduction in pulmonary artery pressure and regression of right ventricular hypertrophy. Circulation 76:135-141, 1987
3. Spah F, Kottman R, Schmidt U: Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung disease. J Cardiovasc Pharmacol 23:517-524, 1994
4. Gassner A, Sommer G, Fridrich L, et al: Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Chest 98:829-834, 1990
5. Takahashi T, Kanda T, Imai S, et al: Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension. Cardivasc Drug Ther 9:809-814, 1995
6. Shmuel I, Scrader BJ, Kauffman E, et al: Effects of adenosine in combination with calcium channel blocks in patients with primary pulmonary hypertension. J Am Coll Cardiol 21:413-418, 1993
7. Davidson A, Basset A, Dab I: Acute effect of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension. Pediatr Pulmonol 6:53-59, 1989
8. Houde C, Bohn DJ, Freedom RM, et al: Profile of pediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J 70:461-468, 1993
9. Weir EK, Rubin LJ, Ayers SM, et al: The acute administration of vasodilators in primary pulmonary hypertension: Experience from the National Institutes of Health registry on primary pulmonary hypertension. Am Rev Respir Dis 140:1623-1630, 1989
10. Bos AP, Tibboel D, Hazebroek FW, et al: Congenital diaphramatic hernia: Impact of prostanoids in the perioperative period. Arch Dis Child 65:994-995, 1990